Photoleukomelanodermatitis of Kobori
| Photoleukomelanodermatitis of Kobori | |
|---|---|
| Synonyms | Kobori's photoleukomelanodermatitis |
| Pronounce | N/A |
| Specialty | Dermatology |
| Symptoms | Skin pigmentation changes, hypopigmentation, hyperpigmentation |
| Complications | N/A |
| Onset | N/A |
| Duration | N/A |
| Types | N/A |
| Causes | Photosensitivity reaction |
| Risks | Exposure to ultraviolet light |
| Diagnosis | Clinical evaluation, skin biopsy |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | Avoidance of UV light, topical corticosteroids |
| Medication | N/A |
| Prognosis | Generally good with avoidance of triggers |
| Frequency | Rare |
| Deaths | N/A |
Photoleukomelanodermatitis of Kobori is a rare skin disorder characterized by the presence of both hyperpigmented and hypopigmented macules on the skin. It was first described by Japanese dermatologist Yasushi Kobori in 1978. The condition is also known as Kobori's disease.
Etiology
The exact cause of Photoleukomelanodermatitis of Kobori is unknown. However, it is believed to be associated with prolonged exposure to ultraviolet radiation, particularly UVB rays. Some researchers also suggest a possible genetic predisposition.
Symptoms
The primary symptom of Photoleukomelanodermatitis of Kobori is the appearance of irregularly shaped, dark brown and white patches on the skin. These patches are usually found on sun-exposed areas such as the face, neck, and arms. Other symptoms may include mild itching and a burning sensation.
Diagnosis
Diagnosis of Photoleukomelanodermatitis of Kobori is primarily based on clinical examination and patient history. Dermoscopy and skin biopsy may be used to confirm the diagnosis and rule out other skin conditions.
Treatment
There is currently no specific treatment for Photoleukomelanodermatitis of Kobori. Management of the condition primarily involves avoiding sun exposure and using sun protection measures such as sunscreen and protective clothing. Topical treatments such as hydroquinone and tretinoin may be used to lighten hyperpigmented areas.
Prognosis
The prognosis for Photoleukomelanodermatitis of Kobori is generally good. The condition is not life-threatening, but it can cause significant cosmetic concern for the patient. Regular follow-up with a dermatologist is recommended to monitor the condition and manage any symptoms.
See also
This article is a skin-condition stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
